Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells.
Nakayama S, Torikoshi Y, Takahashi T, Yoshida T, Sudo T, Matsushima T, Kawasaki Y, Katayama A, Gohda K, Hortobagyi GN, Noguchi S, Sakai T, Ishihara H, Ueno NT. Nakayama S, et al. Among authors: torikoshi y. Breast Cancer Res. 2009;11(1):R12. doi: 10.1186/bcr2231. Epub 2009 Feb 24. Breast Cancer Res. 2009. PMID: 19239702 Free PMC article.
A new cancer diagnostic system based on a CDK profiling technology.
Ishihara H, Yoshida T, Kawasaki Y, Kobayashi H, Yamasaki M, Nakayama S, Miki E, Shohmi K, Matsushima T, Tada S, Torikoshi Y, Morita M, Tamura S, Hino Y, Kamiyama J, Sowa Y, Tsuchihashi Y, Yamagishi H, Sakai T. Ishihara H, et al. Among authors: torikoshi y. Biochim Biophys Acta. 2005 Sep 25;1741(3):226-33. doi: 10.1016/j.bbadis.2005.06.001. Biochim Biophys Acta. 2005. PMID: 15990281 Free article.
Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers.
Kim SJ, Nakayama S, Shimazu K, Tamaki Y, Akazawa K, Tsukamoto F, Torikoshi Y, Matsushima T, Shibayama M, Ishihara H, Noguchi S. Kim SJ, et al. Among authors: torikoshi y. Ann Oncol. 2012 Apr;23(4):891-7. doi: 10.1093/annonc/mdr340. Epub 2011 Aug 4. Ann Oncol. 2012. PMID: 21821547 Free article. Clinical Trial.
C/EBPβ is required for survival of Ly6C- monocytes.
Tamura A, Hirai H, Yokota A, Kamio N, Sato A, Shoji T, Kashiwagi T, Torikoshi Y, Miura Y, Tenen DG, Maekawa T. Tamura A, et al. Among authors: torikoshi y. Blood. 2017 Oct 19;130(16):1809-1818. doi: 10.1182/blood-2017-03-772962. Epub 2017 Aug 14. Blood. 2017. PMID: 28807982 Free PMC article.